Amarin Corp Plc (AMRN)

[couldbebetter]

Bouf, The issue is not with the great product...the issue is the many
deceitful products that are actually worthless masquerading as great
products that do not have to follow the same rules that AMRN must follow.
A patient cannot go out and write themselves a scrip for Vascepa...only
those with legal authority to write scrips can. What AMRN must do
is educate those scrip writers so they will understand why Vascepa
is critical to the health of their CVD and Diabetes patients. If the
scrip writer is not sold on Vascepa, the patient will not benefit.
The whole point of Vascepa being a prescription medication is so that
it can be dispensed to those who truly need the medication and are likely
to benefit from its use. BP has sales reps so they can provide their
clients with useful information about how a particular drug should be
used so it is effective in the patient population it is intended for.